West Paces Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $408K | Buy |
1,126
+17
| +2% | +$5.82K | 0.07% | 116 |
|
|
2026
Q1 | $390K | Hold |
1,109
| – | – | 0.08% | 109 |
|
|
2025
Q4 | $363K | Buy |
1,109
+51
| +5% | +$16.2K | 0.07% | 114 |
|
|
2025
Q3 | $299K | Buy |
1,058
+5
| +0.5% | +$1.45K | 0.06% | 117 |
|
|
2025
Q2 | $294K | Hold |
1,053
| – | – | 0.06% | 120 |
|
|
2025
Q1 | $328K | Sell |
1,053
-153
| -13% | -$45.2K | 0.07% | 107 |
|
|
2024
Q4 | $314K | Sell |
1,206
-480
| -28% | -$142K | 0.08% | 109 |
|
|
2024
Q3 | $543K | Sell |
1,686
-163
| -9% | -$53.3K | 0.13% | 76 |
|
|
2024
Q2 | $578K | Sell |
1,849
-9
| -0.5% | -$2.64K | 0.15% | 70 |
|
|
2024
Q1 | $528K | Buy |
1,858
+39
| +2% | +$11.4K | 0.14% | 74 |
|
|
2023
Q4 | $524K | Buy |
1,819
+534
| +42% | +$145K | 0.15% | 71 |
|
|
2023
Q3 | $345K | Sell |
1,285
-227
| -15% | -$56.6K | 0.11% | 94 |
|
|
2023
Q2 | $336K | Sell |
1,512
-155
| -9% | -$36K | 0.1% | 102 |
|
|
2023
Q1 | $403K | Sell |
1,667
-42
| -2% | -$10.3K | 0.13% | 92 |
|
|
2022
Q4 | $449K | Buy |
1,709
+34
| +2% | +$9.11K | 0.14% | 88 |
|
|
2022
Q3 | $378K | Sell |
1,675
-61
| -4% | -$14.8K | 0.13% | 94 |
|
|
2022
Q2 | $422K | Sell |
1,736
-92
| -5% | -$22.5K | 0.14% | 91 |
|
|
2022
Q1 | $442K | Buy |
1,828
+27
| +1% | +$6.2K | 0.14% | 90 |
|
|
2021
Q4 | $405K | Sell |
1,801
-1,374
| -43% | -$290K | 0.13% | 91 |
|
|
2021
Q3 | $675K | Buy |
3,175
+289
| +10% | +$66.5K | 0.24% | 68 |
|
|
2021
Q2 | $703K | Sell |
2,886
-45
| -2% | -$11.1K | 0.26% | 62 |
|
|
2021
Q1 | $729K | Buy |
2,931
+57
| +2% | +$13.6K | 0.29% | 61 |
|
|
2020
Q4 | $661K | Sell |
2,874
-318
| -10% | -$73.3K | 0.29% | 63 |
|
|
2020
Q3 | $811K | Sell |
3,192
-27
| -0.8% | -$6.69K | 0.41% | 47 |
|
|
2020
Q2 | $759K | Hold |
3,219
| – | – | 0.41% | 49 |
|
|
2020
Q1 | $653K | Sell |
3,219
-228
| -7% | -$49.8K | 0.41% | 45 |
|
|
2019
Q4 | $831K | Buy |
3,447
+68
| +2% | +$15K | 0.45% | 48 |
|
|
2019
Q3 | $654K | Sell |
3,379
-1,418
| -30% | -$272K | 0.39% | 55 |
|
|
2019
Q2 | $884K | Sell |
4,797
-1,243
| -21% | -$223K | 0.55% | 37 |
|
|
2019
Q1 | $1.15M | Sell |
6,040
-1,013
| -14% | -$193K | 0.8% | 26 |
|
|
2018
Q4 | $1.37M | Sell |
7,053
-19
| -0.3% | -$3.71K | 1.06% | 18 |
|
|
2018
Q3 | $1.47M | Sell |
7,072
-38
| -0.5% | -$7.49K | 1.06% | 15 |
|
|
2018
Q2 | $1.31M | Buy |
7,110
+16
| +0.2% | +$2.83K | 0.98% | 18 |
|
|
2018
Q1 | $1.21M | Buy |
7,094
+1,887
| +36% | +$346K | 0.9% | 23 |
|
|
2017
Q4 | $905K | Sell |
5,207
-49
| -0.9% | -$8.67K | 0.67% | 35 |
|
|
2017
Q3 | $980K | Buy |
5,256
+612
| +13% | +$108K | 0.74% | 27 |
|
|
2017
Q2 | $800K | Sell |
4,644
-222
| -5% | -$36.1K | 0.63% | 36 |
|
|
2017
Q1 | $798K | Buy |
4,866
+426
| +10% | +$70.8K | 0.64% | 37 |
|
|
2016
Q4 | $649K | Buy |
+4,440
| New | +$668K | 0.61% | 40 |
|
Other funds holding AMGN
West Paces Advisors's AMGN Position: Q2 2026 in Review
West Paces Advisors increased its Amgen (AMGN) stake by 1.5% in Q2 2026, buying an estimated $5.82K and bringing the position to 1,126 shares worth $408K. The position accounts for 0.07% of the portfolio, ranked #116.
West Paces Advisors first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.47M in Q3 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- West Paces Advisors held 1,126 shares of Amgen worth $408K as of Q2 2026.
- West Paces Advisors bought 17 Amgen shares in Q2 2026, an estimated $5.82K.
- Amgen made up 0.07% of West Paces Advisors's portfolio in Q2 2026, its #116 holding.
- West Paces Advisors first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
- West Paces Advisors's Amgen position peaked at $1.47M in Q3 2018.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.